267 related articles for article (PubMed ID: 31348240)
21. Magnetic resonance-guided laser interstitial thermal therapy versus stereoelectroencephalography-guided radiofrequency thermocoagulation for drug-resistant epilepsy: A systematic review and meta-analysis.
Wang Y; Xu J; Liu T; Chen F; Chen S; Xie Z; Fang T; Liang S
Epilepsy Res; 2020 Oct; 166():106397. PubMed ID: 32590289
[TBL] [Abstract][Full Text] [Related]
22. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Marson AG; Tudur Smith C
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001904. PubMed ID: 30353945
[TBL] [Abstract][Full Text] [Related]
23. Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Sudell M; Tudur Smith C; Marson AG
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012065. PubMed ID: 31233229
[TBL] [Abstract][Full Text] [Related]
24. Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Tudur Smith C; Weston J; Marson AG
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD001031. PubMed ID: 29952431
[TBL] [Abstract][Full Text] [Related]
25. Stiripentol add-on therapy for drug-resistant focal epilepsy.
Brigo F; Igwe SC; Bragazzi NL
Cochrane Database Syst Rev; 2020 May; 5(5):CD009887. PubMed ID: 32468572
[TBL] [Abstract][Full Text] [Related]
26. Genetic generalized and focal epilepsy prevalence in the North American SUDEP Registry.
Verducci C; Friedman D; Donner E; Devinsky O
Neurology; 2020 Apr; 94(16):e1757-e1763. PubMed ID: 32217773
[TBL] [Abstract][Full Text] [Related]
27. Lacosamide add-on therapy for partial epilepsy.
Weston J; Shukralla A; McKay AJ; Marson AG
Cochrane Database Syst Rev; 2015 Jun; (6):CD008841. PubMed ID: 26077821
[TBL] [Abstract][Full Text] [Related]
28. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
Nolan SJ; Marson AG; Weston J; Tudur Smith C
Cochrane Database Syst Rev; 2015 Aug; (8):CD001911. PubMed ID: 26275105
[TBL] [Abstract][Full Text] [Related]
29. Lamotrigine add-on for drug-resistant partial epilepsy.
Ramaratnam S; Panebianco M; Marson AG
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD001909. PubMed ID: 27329345
[TBL] [Abstract][Full Text] [Related]
30. Gabapentin add-on treatment for drug-resistant focal epilepsy.
Panebianco M; Al-Bachari S; Hutton JL; Marson AG
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD001415. PubMed ID: 33434292
[TBL] [Abstract][Full Text] [Related]
31. Scoping review of rational polytherapy in patients with drug-resistant epilepsy.
Grinalds MS; Yoder C; Krauss Z; Chen AM; Rhoney DH
Pharmacotherapy; 2023 Jan; 43(1):53-84. PubMed ID: 36484111
[TBL] [Abstract][Full Text] [Related]
32. Pregabalin add-on for drug-resistant focal epilepsy.
Panebianco M; Bresnahan R; Hemming K; Marson AG
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD005612. PubMed ID: 31287157
[TBL] [Abstract][Full Text] [Related]
33. Surgical outcomes between temporal, extratemporal epilepsies and hypothalamic hamartoma: systematic review and meta-analysis of MRI-guided laser interstitial thermal therapy for drug-resistant epilepsy.
Barot N; Batra K; Zhang J; Klem ML; Castellano J; Gonzalez-Martinez J; Bagic A
J Neurol Neurosurg Psychiatry; 2022 Feb; 93(2):133-143. PubMed ID: 34321344
[TBL] [Abstract][Full Text] [Related]
34. The prevalence of drug-resistant-epilepsy and its associated factors in patients with epilepsy.
Mohammadzadeh P; Nazarbaghi S
Clin Neurol Neurosurg; 2022 Feb; 213():107086. PubMed ID: 35063723
[TBL] [Abstract][Full Text] [Related]
35. Clinical characterization of status epilepticus in childhood: a retrospective study in 124 patients.
Chiarello D; Duranti F; Lividini A; Maltoni L; Spadoni C; Taormina S; Cordelli DM; Franzoni E; Parmeggiani A
Seizure; 2020 May; 78():127-133. PubMed ID: 32371369
[TBL] [Abstract][Full Text] [Related]
36. Vagus nerve stimulation for partial seizures.
Panebianco M; Rigby A; Weston J; Marson AG
Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD002896. PubMed ID: 25835947
[TBL] [Abstract][Full Text] [Related]
37. Sodium valproate versus phenytoin monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Marson AG; Weston J; Tudur Smith C
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD001769. PubMed ID: 30091458
[TBL] [Abstract][Full Text] [Related]
38. Brivaracetam add-on therapy for drug-resistant epilepsy.
Bresnahan R; Panebianco M; Marson AG
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD011501. PubMed ID: 30920649
[TBL] [Abstract][Full Text] [Related]
39. Early Predictors of Drug-Resistant Epilepsy Development after Convulsive Status Epilepticus.
Yuan F; Jia R; Gao Q; Yang F; Yang X; Jiang Y; Li W; Marcuse LV; Jiang W
Eur Neurol; 2018; 79(5-6):325-332. PubMed ID: 29986342
[TBL] [Abstract][Full Text] [Related]
40. Oxcarbazepine add-on for drug-resistant focal epilepsy.
Bresnahan R; Atim-Oluk M; Marson AG
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012433. PubMed ID: 32129501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
